GRPH
Graphite Bio, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Kimberlee Cobleigh Drapkin CPA
IPO Date
2021-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Graphite Bio, Inc.
CEO
Kimberlee Cobleigh Drapkin CPA
IPO Date
2021-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 0 |
| $0.00 |
| 21 Jul 2023 | Hege Kristen | director | A-Award | Acquired | 20,000 | $2.72 |
| 21 Jul 2023 | Viney Joanne L. | director | A-Award | Acquired | 20,000 | $2.72 |
| 21 Jul 2023 | Carlo Rizzuto | director | A-Award | Acquired | 20,000 | $2.72 |
| 21 Jul 2023 | JIMENEZ JOSEPH | director | A-Award | Acquired | 20,000 | $2.72 |
| 21 Jul 2023 | KARSEN PERRY A | director | A-Award | Acquired | 20,000 | $2.72 |
| 21 Jul 2023 | Jerel Davis | director | A-Award | Acquired | 20,000 | $2.72 |
| 23 Feb 2023 | Lehrer-Graiwer Joshua | director, officer: PRESIDENT AND CEO | A-Award | Acquired | 600,000 | $2.18 |
| 6 Jan 2023 | EcoR1 Capital, LLC | director | Disposed | 0 | $0.00 |